GCG and polycystic ovary syndrome: Until now, only one study has addressed GLP1 agonist treatment in PCOS, providing evidence that combined treatment with short-acting GLP1 receptor agonist exenatide and metformin was superior to exenatide and metformin monotherapies in improving menstrual cyclicity, ovulation rate, androgens, insulin sensitivity measures, and weight loss (11).